Uterine fibroids

The Abnormal Menstrual Cycle

Volumn , Issue , 2005, Pages 79-93

  Morrison, J ^a   MacKenzie, I Z ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38949139931     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Cramer SF, Patel A. The frequency of uterine leiomyomas.Am J Clin Pathol 1990; 94: 435-8
2. MacKenzie IZ, Naish C, Rees M, Manek S. 1170 consecutive hysterectomies: indications and pathology. J Br Menopause Soc 2004; 10: 108-12
3. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol 1990; 97: 285-98
4. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.Obstet Gynecol 1997; 90: 967-73
5. Treloar SA, Martin NG, Dennerstein L, et al. Pathways to hysterectomy: insights from longitudinal twin research. Am J Obstet Gynecol 1992; 167: 82-8
6. Lepine LA, Hillis SD, Marchbanks PA, et al. Hysterectomy surveillance - United States, 1980-1993. MMWR CDC Surveill Summ 1997; 46: 1-15
7. Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 1995; 51: 127-31
8. Rein MS, Friedman AJ, Barbieri RL, et al. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77: 923-6
9. Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970; 107: 1168-73
10. Nilbert M, Heim S, Mandahl N, et al. Different karyotypic abnormalities, t(1; 6) and del(7), in two uterine leiomyomas from the same patient. Cancer Genet Cytogenet 1989; 42: 51-3
11. Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 1998; 70: 432-9
12. Parazzini F, Negri E, La Vecchia C, Chatenoud, et al. Reproductive factors and risk of uterine fibroids. Epidemiology 1996; 7: 440-2
13. Ross RK, Pike MC, Vessey MP, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 1986; 293: 359-62
14. Walker CL, Cesen-Cummings K, Houle C, et al. Protective effect of pregnancy for development of uterine leiomyoma. Carcinogenesis 2001; 22: 2049-52
15. Filicori M, Hall DA, Loughlin JS, et al. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 1983; 147: 726-7
16. Lumbiganon P, Rugpao S, Phandhu-fung S, et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996; 103: 909-14
17. Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 1993; 76: 513-17
18. Clevenger-Hoeft M, Syrop CH, Stovall DW, et al. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 1999; 94: 516-20
19. Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 2001; 56: 483-91
20. Hart R, Khalaf Y, Yeong CT, et al. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod 2001; 16: 2411-17
21. Aharoni A, Reiter A, Golan D, et al. Patterns of growth of uterine leiomyomas during pregnancy.A prospective longitudinal study. Br J Obstet Gynaecol 1988; 95: 510-13
22. Rosati P, Exacoustos C, Mancuso S. Longitudinal evaluation of uterine myoma growth during pregnancy.A sonographic study. J Ultrasound Med 1992; 11: 511-15
23. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study.Obstet Gynecol 2000; 95: 764-9
24. Hamoda H, Chamberlain PF, Moore NR, et al. Conservative treatment of an incarcerated gravid uterus. Br J Obstet Gynaecol 2002; 109: 1074-5
25. Arrastia CD, Fruchter RG, Clark M, et al. Uterine carcinosarcomas: incidence and trends in management and survival. Gynecol Oncol 1997; 65: 158-63
26. Riddle PJ, Echeta CB, Manek S, et al. Retrospective study of the management of uterine sarcomas at Oxford 1990-1998. Role of adjuvant treatment. Clin Oncol 2002; 14: 54-61
27. Murphy NJ, Wallace DL. Gonadotropin releasing hormone (GnRH) agonist therapy for reduction of leiomyoma volume. Gynecol Oncol 1993; 49: 266-7
28. Harper RS, Scully RE. Intravenous leiomyomatosis of the uterus.A report of four cases.Obstet Gynecol 1961; 18: 519-29
29. Kohama T, Shinohara K, Takahura M, et al. Large uterine myoma with erythropoietin messenger RNA and erythrocytosis. Obstet Gynecol 2000; 96: 826-8
30. Suzuki M, Takamizawa S, Nomaguchi K, et al. Erythropoietin synthesis by tumor tissues in a patient with uterine myoma and erythrocytosis. Br J Haematol 2001; 113: 49-51
31. Lakhani KP, Marsh MS, Purcell W, Hardiman P. Uterine artery blood flow parameters in women with dysfunctional uterine bleeding and uterine fibroids: the effects of tranexamic acid. Ultrasound Obstet Gynecol 1998; 11: 283-5
32. Starczewski A, Iwanicki M. Intrauterine therapy with levonorgestrel releasing IUD of women with hypermenorrhea secondary to uterine fibroids. Ginekol Pol 2000; 71: 1221-5
33. Wildemeersch D, Schacht E. The effect on menstrual blood loss in women with uterine fibroids of a novel ‘frameless’ intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Eur J Obstet Gynecol Reprod Biol 2002; 102: 74-9
34. Kettel LM, Murphy AA, Morales AJ, et al. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril 1993; 60: 642-6
35. Matta WH, Shaw RW, Nye M. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynaecol 1989; 96: 200-6
36. Lethaby A, Vollenhoven B, Sowter M. Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software, 2003
37. Hammar M, Christau S, Nathorst-Boos J, et al. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998; 105: 904-11
38. Eisinger SH, Meldrum S, Fiscella K, et al. Lowdose mifepristone for uterine leiomyomata. Obstet Gynecol 2003; 101: 243-50
39. Reiter RC, Wagner PL, Gambone JC. Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal. Obstet Gynecol 1992; 79: 481-4
40. Carlson KJ, Miller BA, Fowler FJ Jr.The Maine Women’s Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994; 83: 566-72
41. Ferrari MM, Berlanda N, Mezzopane R, et al. Identifying the indications for laparoscopically assisted vaginal hysterectomy: a prospective, randomised comparison with abdominal hysterectomy in patients with symptomatic uterine fibroids. Br J Obstet Gynaecol 2000; 107: 620-5
42. Mais V, Ajossa S, Guerriero S, et al. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 1996; 174: 654-8
43. Seracchioli R, Rossi S, Govoni F, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 2000; 15: 2663-8
44. Milad MP, Morrison K, Sokol A, et al. A comparison of laparoscopic supracervical hysterectomy vs. laparoscopically assisted vaginal hysterectomy. Surg Endosc 2001; 15: 286-8
45. Palerme GR, Friedman EA. Rupture of the gravid uterus in the third trimester. Am J Obstet Gynecol 1966; 94: 571-6
46. Nezhat CH, Nezhat F, Roemisch M, et al. Pregnancy following laparoscopic myomectomy: preliminary results. Hum Reprod 1999; 14: 1219-21
47. Dubuisson JB, Fauconnior A, Deffarges JV, et al. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod 2000; 15: 869-73
48. Heaston DK, Mineau DE, Brown BJ, Miller FJ Jr. Transcatheter arterial embolization for control of persistent massive puerperal hemorrhage after bilateral surgical hypogastric artery ligation. Am J Roentgenol 1979; 133: 152-4
49. Ravina JH, Merland JJ, Herbreteau D, et al. Preoperative embolization of uterine fibroma. Preliminary results (10 cases). Presse Med 1994; 23: 1540
50. Ravina JH, Herbreteau D, Ciraru-Vigneron N, et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-2
51. Reidy JF, Bradley EA. Uterine artery embolization for fibroid disease. Cardiovasc Intervent Radiol 1998; 21: 357-60
52. Bradley EA, Reidy JF, Forman RG, et al. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998; 105: 235-40
53. Ravina JH, Vigneron NC, Aymard A, et al. Pregnancy after embolization of uterine myoma: report of 12 cases. Fertil Steril 2000; 73: 1241-3
54. National Institute for Clinical Excellence. Uterine Artery Embolisation for Fibroids. London: National Institute for Clinical Excellence, 2003
55. Royal College of Obstetricians and Gynaecologists and Royal College of Radiologists. Clinical Recommendations on the Use of Uterine Artery Embolisation in the Management of Fibroids. Report of a Joint Working Party of the RCOG and RCR. London: RCOG Press, 2001